Study Claims Nasal Drops Treatment Could Lead To Quick Recovery From Stroke

The study shows that the C3a peptide affects the function of astrocytes, that is, cells that control many of the nerve cells.

In a ground-breaking finding, researchers have discovered that nasal drops containing a specific chemical can aid mice in recovering from the harmful biological effects of a stroke.

Researchers now have higher hopes for the treatment's future applicability to humans because of this breakthrough.

According to a release by the University of Gothenburg, the work now published in the Journal of Clinical Investigation is a multicenter study in which researchers implemented parallel testing of an experimental stroke treatment on mice. The study was conducted in collaboration with researchers at the Czech Academy of Sciences.

By giving mice a molecule, the complement peptide C3a, in nasal drops, the scientists saw them recover motor function faster and better after stroke compared with mice that had received nasal drops with a placebo.